SPP1 and central nervous system cancer: A comparison of high- and low-grade gliomas revealed a subpopulation of astrocytes expressing high levels of osteopontin (SPP1) in high-grade gliomas, suggesting a correlation with poor survival among glioma patients (46, 47).